Translational Lung Cancer Research

Translational Lung Cancer Research

转化肺癌研究

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Translational Lung Cancer Research》是由Society for Translational Medicine (STM)出版社于2012年创办的英文国际期刊(ISSN: 2218-6751,E-ISSN: 2226-4477),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为Medicine-Oncology。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比0.8259...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比84.30%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在172篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Translational Lung Cancer Research审稿周期约为 In-house review: 1-3 weeks; External peer review: 1-3 months; Publication Ahead of Print: within 1 month after being accepted 。该刊近年未被列入国际预警名单,年发文量约172篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 172 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
3区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
RESPIRATORY SYSTEM 呼吸系统 ONCOLOGY 肿瘤学
3区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 95 / 322

70.7%

学科:RESPIRATORY SYSTEM SCIE Q1 22 / 100

78.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 102 / 322

68.48%

学科:RESPIRATORY SYSTEM SCIE Q2 34 / 101

66.83%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7.2 SJR:1.318 SNIP:0.948
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 92 / 404

77%

期刊发文

  • Case report: targeted sequencing improves the diagnosis of multiple synchronous lung cancers

    Author: Ba, Yufeng; Li, Haomiao; Zhu, Jianping; Wang, Haoran; Lv, Hongwei; Guo, Chongqing; Sun, Rui; Zheng, Jiawen; Meng, Lin; Shi, Shanshan

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-23-155

  • Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA

    Author: Ling, Xiaodong; Zhang, Luquan; Fang, Chengyuan; Liang, Hao; Zhu, Jinhong; Ma, Jianqun

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-23-157

  • Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101)

    Author: Wang, Rong; Shi, Meiqi; Ji, Mei; Han, Zhengxiang; Chen, Lingxiang; Liu, Yong; Lu, Kaihua; Liu, Lianke; Chen, Bi; Zhang, Xizhi; Miao, Liyun; Shu, Yongqian

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-23-121

  • Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis

    Author: Zhang, Mai; Huang, Qian; Yu, Min; Xue, Jianxin; Huang, Meijuan; Lu, You; Zhang, Yan

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-23-167

  • A new preoperative localization of pulmonary nodules guided by mixed reality: a pilot study of an animal model

    Author: Xin, Ning; Wu, Xiaoyu; Chen, Zihao; Wei, Rongqiang; Saito, Yuichi; Lachkar, Samy; Salvicchi, Alberto; Fumimoto, Satoshi; Drevet, Gabrielle; Xu, Zhifei; Huang, Kenan; Tang, Hua

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-22-884

  • Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study

    Author: Zhao, Guangyin; Zhang, Hongyu; Xu, Fengkai; Lu, Chunlai; Zhu, Qiaoliang; Grossi, Francesco; Divisi, Duilio; Ma, Teng; Gu, Jie; Ge, Di

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-22-871

  • Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real- world retrospective observational study (CTONG2004-ADV)

    Author: Xu, Chong-Rui; Chen, Qixun; Zhou, Chengzhi; Wu, Lin; Li, Wen; Zhang, Huizhong; Li, Yongsheng; Xu, Fei; Xiong, Jianping; Wang, Qiming; Zhang, Haibo; Jiang, Yuequan; Yin, Haitao; Wu, Qingchen; Dai, Qiangsheng; Hu, Jian; Chen, Jianhua; Zhang, Jian; Wu, Gang; Yin, Jun; Zhao, Jianfu; Liu, Baogang; Shan, Jianzhen; Sheng, Liming; Chen, Qunqing; Han, Zhengxiang; Shi, Huaqiu; Liu, Yimin; Chen, Jun; Wu, Yi-Long

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-22-852

  • Integrated analysis reveals the microenvironment of non-small cell lung cancer and a macrophage-related prognostic model

    Author: Xie, Shenglong; Huang, Guixiang; Qian, Weiwei; Wang, Xuyang; Zhang, Hanlu; Li, Zhiyang; Liu, Yu; Wang, Yun; Yu, Hongtao

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.21037/tlcr-22-866